1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester
- CAS No.
- 1403474-70-3
- Chemical Name:
- 1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester
- Synonyms
- Azilsartan Ethyl Ester Impurity;Azilsartan-22;Ethyl Azilsartan;Azilsartan impurity V;Azilsartan ethyl ester;ethyl ester of azilsartan;Azilsartan Acid Ethyl Ester;Azilsartan Kamedoxomil Impurity;methyl 2-(bis(tert-butoxycarbonyl)amino)-3-nitrobenzoate;1H-Benzimidazole-7-carboxylicacid,1-[[2'-(2,5-dihydro-5-oxo-...
- CBNumber:
- CB12645154
- Molecular Formula:
- C27H24N4O5
- Molecular Weight:
- 484.5
- MDL Number:
- MFCD28404679
- MOL File:
- 1403474-70-3.mol
- MSDS File:
- SDS
| Product description | Number | Pack Size | Price |
| Ethyl 2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | 448910 | 100mg | $382 |
| Ethyl 2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | 448910 | 250mg | $566 |
| Ethyl 2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | DGC47470 | 25mg | $900 |
| Ethyl 2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | DGC47470 | 250mg | $900 |
| Ethyl 2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | DGC47470 | 100mg | $900 |
| More product size | |||
1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester Properties
| Melting point | 171-175°C |
|---|---|
| Density | 1.34±0.1 g/cm3 (20 ºC 760 Torr) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| pka | 6.99±0.20(Predicted) |
| form | Solid |
| color | White to Light Yellow |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H315-H319 |
| Precautionary statements | P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 |
1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester price More Price(27)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Usbiological | 448910 | Ethyl 2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | 1403474-70-3 | 100mg | $382 | 2026-06-03 | Buy |
| Usbiological | 448910 | Ethyl 2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | 1403474-70-3 | 250mg | $566 | 2026-06-03 | Buy |
| Biosynth | DGC47470 | Ethyl 2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | 1403474-70-3 | 25mg | $900 | 2026-06-04 | Buy |
| Biosynth | DGC47470 | Ethyl 2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | 1403474-70-3 | 250mg | $900 | 2026-06-04 | Buy |
| Biosynth | DGC47470 | Ethyl 2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | 1403474-70-3 | 100mg | $900 | 2026-06-04 | Buy |
1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester Chemical Properties,Uses,Production
Uses
Ethyl 2-Ethoxy-1-((2''-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1''-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate is an impurity of Azilsartan (A926900), which is an analgesic and anti-inflammatory drug containing angiotensin II antagonists.
Synthesis
1397836-41-7
105-58-8
1403474-70-3
The synthesis of 1-[[2'-(2'-(N'-hydroxyformamidinyl)-[1,1'-biphenyl]-4-yl]methyl]-1H-benzo[d]imidazole-7-carboxylic acid ethyl ester and diethyl carbonate was carried out using ethyl 2-ethoxime (II) and diethyl carbonate as the raw materials for the synthesis of 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-2-ethoxime (II) The general procedure for ethyl -7-carboxylate was as follows: ethoxime (II) (390 g, 851 mmol) was suspended in 3600 mL of diethyl carbonate. The suspension was heated to 65°C. An ethanolic solution of sodium ethoxide (21%, 400 mL, 1072 mmol) was added dropwise to the reaction mixture over 30 minutes at 65°C. After the dropwise addition, the reaction mixture was continued to be stirred at 65 °C for 30 min. Subsequently, the reaction mixture was cooled to 60 °C and water (1350 mL) was added. The resulting emulsion was stirred for at least 15 minutes. After separation of the layers, the organic phase was extracted with water (1350 mL). The aqueous phase extracts were combined, diluted with ethanol (1350 mL) and the temperature was adjusted to 40 °C. Acetic acid (111 mL, 1940 mmol) was added dropwise to the solution over 40 minutes at 40°C. The regenerated suspension was stirred at 40 °C for 30 min and then cooled to 20 °C. The solid product was separated by suction filtration and washed with water (2 x 450 mL). Finally, the product was dried in a vacuum desiccator at 45 °C to give 397 g of azilsartan ethyl ester (III) in 86% yield of the theoretical amount and 95.8% HPLC purity.
References
[1] Patent: WO2016/58563, 2016, A1. Location in patent: Page/Page column 7
[2] Patent: WO2012/139536, 2012, A1. Location in patent: Page/Page column 21
1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester Preparation Products And Raw materials
Raw materials
1of2
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| ShenZhen H&D Pharmaceutical Technology Co., LTD | +86-18627948422 | sale@hdimpurity.com | China | 3681 | 58 |
| ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD | +86-15225627621 +86-13213167925 | jiuyitime@fdachem.com | China | 16511 | 58 |
| Standardpharm Co. Ltd. | 86-714-3992388 | overseasales1@yongstandards.com | United States | 14332 | 58 |
| career henan chemical co | +86-0371-86658258 | factory@coreychem.com | China | 29792 | 58 |
| Dideu Industries Group Limited | +86-29-89586680 +86-15129568250 | 1059@dideu.com | China | 29093 | 58 |
| AFINE CHEMICALS LIMITED | +86-571-85134551 +86-18958018566 | info@afinechem.com | China | 15079 | 58 |
| BOC Sciences | 16314854226; +8616314854226 | inquiry@bocsci.com | United States | 19853 | 58 |
| Hangzhou Huarong Pharm Co., Ltd. | 571-86758373 +8613588754946 | sales@huarongpharm.com | CHINA | 3148 | 58 |
| Hefei TNJ Chemical Industry Co.,Ltd. | +86-0551-65418684 +86-18949823763 | sales@tnjchem.com | China | 25356 | 58 |
| Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49734 | 58 |
View Lastest Price from 1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-02 | 1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester
1403474-70-3
|
$2.00-5.00 | 1kg | 99% | 100kg | ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD | |
![]() |
2026-03-12 | Azilsartan impurity V | 10mg | 98% | 500mg | ShenZhen H&D Pharmaceutical Technology Co., LTD | ||
![]() |
2026-03-12 | Azilsartan impurity Y
1403474-70-3
|
10mg | 98% | 500mg | ShenZhen H&D Pharmaceutical Technology Co., LTD |
-
![1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester pictures](/ProductImageEN1/2025-06/Small/c358fa69-1819-4156-ba31-628c5e0ffa9e.png)
- 1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester
1403474-70-3
- $2.00-5.00
- 99%
- ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
-

- Azilsartan impurity V
- 98%
- ShenZhen H&D Pharmaceutical Technology Co., LTD
-

- Azilsartan impurity Y
1403474-70-3
- 98%
- ShenZhen H&D Pharmaceutical Technology Co., LTD
1403474-70-3(1H-BenziMidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]Methyl] -2-ethoxy-, ethyl ester)Related Search:
1of4





